Hashimoto's thyroiditis Flashcards
epidemiology of hashimoto’s thyroiditus
most common form of thyroiditis and most frequent cause of hypothyroidism in US
iodine deficiency is the most common cause of hypothyroidism worldwide
female more
all age group, most common 30-50yrs
pathophysiology of hashimoto’s thyroiditis
unknown aetiology - genetic and env factors likely to play a role
immunological mechanisms:
- associations with HLA-DR3, DR4, DR5 have been proposed
- cellular (especially T cells) and humoral immune responses are activated -> active B lymphocytes produce TPO Ab and Ab against thyroglobulin (TG) –> destruction of the thyroid tissue
associations with hashimoto’s thyroiditis
increased risk of non-hodgkin lymphoma usually originating from B cells
increased risk of autoimmune disease - t1dm, SLE, graves disease, addisons
clinical features of hashimoto’s disease
early stage
- asymptomatic
- goitre - non-tender or painless, rubbery thyroid with moderate and symettrical enlargement
- hashitoxicosis - transient hyperthyroidism due to follicular rupture of horone containing thyroid tissure –> irritability, heat intolerance, diarrhoea
late stage
- thyroid may be normal sized or small if extensive fibrosis has occured
- hypothyroidism eg cold intolerance, constipation, fatigue
Ix for hashimoto’s disease
early stage transient hyperthyroidism possible - low TSH, high free T3 and 4
progression - subclinical hypothyroidism - high TSH, T3 and 4 normal
late stage - overt hypothyroidism - high TSH, low T3 4
anti-TPO +ve (high anti-microsomal Ab)
anti-Tg Ab +ve
high LDL, low HDL, low Hb
US - atrophic phenotype = reduction in thyroid size, goitrous phenotype = heterogenous enlargement
FNAC - exclude malignancy or lymphoma
radioactive iodine uptake test - variable, often patchym irregular. reduced uptake in transient hyperthyroidism
pathology of hashimoto’s disease
diffuse lymphocytic inflitration (cytotoxic T lymphocytes) with germinal centre, oncocytic metaplasic cells (huryhle cells) and fibrotic tissue
treatment of hashimoto’s
levothyroxine for life - start at lower and more slow acting dose with increasing severity of hypothyroidism because of risk of cardiac SE
life long monitoring - of thyroid parameters (TSH) to adjust treatment
complications of Hashimoto’s
permenant hypothyroidism
myxoedema coma
thyroid lymphoma